Official registry condition

Multiple Myeloma peptide trials

18 selected ClinicalTrials.gov records carrying the official condition label Multiple Myeloma. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

18 selected records.

Connected peptides

2 profiles.

Registry update years

2017–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles2

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 34 selected PubMed records and 7 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Multiple Myeloma unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT03606577

PeptideScanner retained ClinicalTrials.gov record NCT03606577 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was carfilzomib.

PeptideScanner change date
November 17, 2026
Cited source date
November 12, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06152575

PeptideScanner retained ClinicalTrials.gov record NCT06152575 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was carfilzomib.

PeptideScanner change date
November 17, 2026
Cited source date
November 12, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07555938

PeptideScanner retained ClinicalTrials.gov record NCT07555938 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was carfilzomib.

PeptideScanner change date
November 17, 2026
Cited source date
November 10, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →